Apoptosis of murine melanoma cells induced by heavy-ion radiation combined with Tp53 gene transfer

References

• Asakawa I, Yoshimura H, Takahashi A, Ohnishi K, Nakagawa H, Ota I, Furusawa Y, Tamamoto T, Ohishi H, Ohnishi T. Radiation-induced growth inhibition in transplanted human tongue carcinomas with different p53 gene status. Anticancer Research 2002; 22: 2037–2043
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Overgaard J, Thames H D, Overgaard M, von der Maase H, Meder J. Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology 1989; 16: 169–182
   PubMed Web of Science ®Google Scholar
• Borgmann K, Roper B, El-Awady R, Brackrock S, Bigalke M, Dork T, Alberti W, Dikomey E, Dahm-Daphi J. Indicators of late normal tissue response after radiotherapy for head and neck cancer: Fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiotherapy and Oncology 2002; 64: 141–152
   PubMed Web of Science ®Google Scholar
• Boulay J L, Perruchoud A P, Reuter J, Bolliger C, Herrmann R, Rochlitz C. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients. Cancer Gene Therapy 2000; 7: 1215–1219
   PubMedGoogle Scholar
• Boyd M, Mairs R J, Keith W N, Ross S C, Welsh P, Akabani G, Owens J, Vaidyanathan G, Carruthers R, Dorrens J, Zalutsky M R. An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radiostatine and harnessing radiation-mediated bystander effects. Journal of Gene Medicine 2004; 6: 937–947
   PubMed Web of Science ®Google Scholar
• Chen C Y, Oliner J D, Zhan Q, Fornace A J, Jr, Vogelstein B, Kastan M B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proceedings of the National Academy of Sciences of the United stated of America 1994; 1: 2684–2688
   Google Scholar
• Chen G T, Castro J R, Quivey J M. Heavy charged particle radiotherapy. Annual Review of Biophysics and Bioengineering 1981; 10: 499–529
   PubMedGoogle Scholar
• Collis S J, DeWeese T L. Enhanced radiation response through directed molecular targeting approaches. Cancer and Metastasis Reviews 2004; 23: 277–292
   PubMed Web of Science ®Google Scholar
• el-Deiry W S, Tokino T, Velculescu V E, Levy D B, Parsons R, Trent J M, Lin D, Mercer W E, Kinzler K W, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825
   PubMed Web of Science ®Google Scholar
• Gridley D S, Slater J M. Combining gene therapy and radiation against cancer. Current Gene Therapy 2004; 4: 231–248
   PubMed Web of Science ®Google Scholar
• Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Shigehara H, Konouchi H, Hisatomi M, Kawasaki S, Hiraki Y, Kishi K. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines. Oncology Reports 2003; 10: 671–677
   PubMed Web of Science ®Google Scholar
• Huh J J, Wolf J K, Fightnmaster D L, Lotan R, Follen M. Transduction of adenovirus-mediated wild-type p53 after radiotherapy in human cervical cancer cells. Gynecologic Oncology 2003; 89: 243–250
   PubMedGoogle Scholar
• Jiang H, Lin J, Su Z Z, Herlyn M, Kerbel R S, Weissman B E, Welch D R, Fisher P B. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 1995; 10: 1855–1864
   PubMed Web of Science ®Google Scholar
• Kachnic L A, Wu B, Wunsch H, Mekeel K L, DeFrank J S, Tang W, Powell S N. The ability of p53 to activate downstream genes p21WAF1/cip1 and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase. The Journal of Biological Chemistry 1999; 274: 13111
   PubMedGoogle Scholar
• Kawabe S, Munshi A, Zumstein L A, Wilson D R, Roth J A, Meyn R E. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts. International Journal of Radiation Biology 2001; 77: 185–194
   PubMed Web of Science ®Google Scholar
• Kim I A, Yang Y J, Yoon S C, Choi I B, Kwon H C, Kim C M, Joe Y A, Kang J K, Hong J K. Potential adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas. International Journal of Oncology 2001; 19: 1041–1047
   PubMedGoogle Scholar
• Kubbutat M H, Jones S N, Vousden K H. Regulation of p53 stability by MDM2. Nature 1997; 387: 299–303
   PubMed Web of Science ®Google Scholar
• Levine A J. P53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323–331
   PubMed Web of Science ®Google Scholar
• McBride W H, Chiang C S, Olson J L, Wang C C, Hong J H, Pajonk F, Dougherty G J, Iwamoto K, Pervan M, Liao Y P. A sense of danger from radiation. Radiation Research 2004; 162: 1–19
   PubMed Web of Science ®Google Scholar
• Murakami M, Eguchi-Kasai K, Sato K, Minohara S, Yatagai F, Kanai T. Differences in heavy-ion-induced DNA double-strand breaks in a mouse DNA repair-deficient mutant cell line (SL3-147) before and after chromatin proteolysis. Journal of Radiation Research 1995; 36: 258–264
   PubMedGoogle Scholar
• Natsugoe S, Nakashima S, Matsumoto M, Xiangming C, Okumura H, Kijima F, Ishigami S, Takebayashi Y, Baba M, Takao S, Aikou T. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clinical Cancer Research 1999; 5: 2445–2449
   PubMedGoogle Scholar
• Nielsen L L, Dell J, Maxwell E, Armstrong L, Maneval D, Catino J J. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Therapy 1997; 4: 129–138
   PubMed Web of Science ®Google Scholar
• Perry M E. Mdm2 in the response to radiation. Molecular Cancer Research 2004; 2: 9–19
   PubMed Web of Science ®Google Scholar
• Pirollo K F, Hao Z, Rait A, Jang Y J, Fee W E, Ryan P, Chiang Y, Chang E H. P53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene 1997; 14: 1735–1746
   PubMed Web of Science ®Google Scholar
• Ritter M A, Cleaver J E, Tobias C. High-LET radiations induce a large proportion of non-rejoining DNA breaks. Nature 1977; 266: 653–655
   PubMed Web of Science ®Google Scholar
• Satyamoorthy K, Chehab N H, Waterman M J, Lien M C, El-Deiry W S, Herlyn M, Halazonetis T D. Aberrant regulation and function of wild-type P53 in radioresistant melanoma cells. Cell Growth & Differentiation 2000; 11: 467–474
   PubMedGoogle Scholar
• Scholz G T, Kraft G. Influence of radiation quality on the yield of DNA strand breaks in SV40 DNA irradiated in solution. Radiation Research 1999; 151: 595
   PubMedGoogle Scholar
• Sheikh M S, Rochefort H, Garcia M. Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 1995; 11: 1899–1905
   PubMed Web of Science ®Google Scholar
• Shields C L, Shields J A, Cater J, Gunduz K, Miyamoto C, Micaily B, Brady L W. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Archives of Ophthalmology 2000; 118: 1219–1228
   PubMedGoogle Scholar
• Shi W, Teschendorf C, Muzyczka N, Siemann D W. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiotherapy and Oncology 2003; 66: 1–9
   PubMedGoogle Scholar
• Spitz F R, Nguyen D, Skibber J M, Meyn R E, Cristiano R J, Roth J A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clinical Cancer Research 1996; 2: 1665–1671
   PubMed Web of Science ®Google Scholar
• Swisher S G, Roth J A. Clinical update of Ad-p53 gene therapy for lung cancer. The Surgical clinics of North America 2002; 11: 521–535
   Google Scholar
• Takahashi A, Matsumoto H, Yuki K, Yasumoto J, Kajiwara A, Aoki M, Furusawa Y, Ohnishi K, Ohnishi T. High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. International Journal of Radiation Oncology, Biology, Physics 2004; 60: 591–597
   PubMed Web of Science ®Google Scholar
• Takahashi A, Ohnishi K, Wang X, Kobayashi M, Matsumoto H, Tamamoto T, Aoki H, Furusawa Y, Yukawa O, Ohnishi T. The dependence of p53 on the radiation enhancement of thermosensitivity at different LET. International Journal of Radiation Oncology, Biology, Physics 2000; 47: 489–494
   PubMed Web of Science ®Google Scholar
• Tsuchida Y, Tsuboi K, Ohyama H, Ohno T, Nose T, Ando K. Cell death induced by high-linear-energy transfer carbon beams in human glioblastoma cell lines. Brain Tumor Pathology 1998; 15: 71–76
   PubMedGoogle Scholar
• Vlachaki M T, Chhikara M, Aguilar L, Zhu X, Chiu K J, Woo S, The B S, Thompson T C, Butler E B, Aguilar-Cordova E. Enhanced therapeutic effect of multiple injections of HSVTK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model. International Journal of Radiation Oncology, Biology, Physics 2001; 51: 1008–1017
   PubMedGoogle Scholar
• Wu C M, Li X Y, Huang T H. Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice. World Journal of Gastroenterology 2004; 10: 3011–3015
   PubMedGoogle Scholar